Myeloproliferative disorders: Biology and management

Richard T. Silver, Ayalew Tefferi

Research output: Book/ReportBook

Abstract

With the recent discovery of JAK2 mutations in myeloproliferative disorders, medical science has taken a revolutionary stride forward toward understanding the pathogenesis of these diseases. This new advancement translates not only to a more rapid and reliable diagnosis, but also allows groundbreaking research into the development of new therapeutics. Written in an easy-to-follow text myeloproliferative disorders gives the practicing clinician a single source answer to classification, diagnosis, management, and recent advances in this disorder.

Original languageEnglish (US)
PublisherCRC Press
Number of pages229
ISBN (Electronic)9781420061635
ISBN (Print)9781420061628
StatePublished - Jan 1 2007

Fingerprint

Myeloproliferative Disorders
Mutation
Research
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Myeloproliferative disorders : Biology and management. / Silver, Richard T.; Tefferi, Ayalew.

CRC Press, 2007. 229 p.

Research output: Book/ReportBook

@book{59b07e433b674fb4aac94c9bf0c85473,
title = "Myeloproliferative disorders: Biology and management",
abstract = "With the recent discovery of JAK2 mutations in myeloproliferative disorders, medical science has taken a revolutionary stride forward toward understanding the pathogenesis of these diseases. This new advancement translates not only to a more rapid and reliable diagnosis, but also allows groundbreaking research into the development of new therapeutics. Written in an easy-to-follow text myeloproliferative disorders gives the practicing clinician a single source answer to classification, diagnosis, management, and recent advances in this disorder.",
author = "Silver, {Richard T.} and Ayalew Tefferi",
year = "2007",
month = "1",
day = "1",
language = "English (US)",
isbn = "9781420061628",
publisher = "CRC Press",

}

TY - BOOK

T1 - Myeloproliferative disorders

T2 - Biology and management

AU - Silver, Richard T.

AU - Tefferi, Ayalew

PY - 2007/1/1

Y1 - 2007/1/1

N2 - With the recent discovery of JAK2 mutations in myeloproliferative disorders, medical science has taken a revolutionary stride forward toward understanding the pathogenesis of these diseases. This new advancement translates not only to a more rapid and reliable diagnosis, but also allows groundbreaking research into the development of new therapeutics. Written in an easy-to-follow text myeloproliferative disorders gives the practicing clinician a single source answer to classification, diagnosis, management, and recent advances in this disorder.

AB - With the recent discovery of JAK2 mutations in myeloproliferative disorders, medical science has taken a revolutionary stride forward toward understanding the pathogenesis of these diseases. This new advancement translates not only to a more rapid and reliable diagnosis, but also allows groundbreaking research into the development of new therapeutics. Written in an easy-to-follow text myeloproliferative disorders gives the practicing clinician a single source answer to classification, diagnosis, management, and recent advances in this disorder.

UR - http://www.scopus.com/inward/record.url?scp=85057272297&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057272297&partnerID=8YFLogxK

M3 - Book

AN - SCOPUS:85057272297

SN - 9781420061628

BT - Myeloproliferative disorders

PB - CRC Press

ER -